Status | Study |
Recruiting |
Study Name: CoHOrt of Cerebral CavernOus maLformATion: multicEnter Prospective Observational Study Condition: Cerebral Cavernous Malformation Intracerebral Hemorrhage Date: 2016-10-26 |
Not yet recruiting |
Study Name: Atorvastatin Therapy in Cerebral Cavernous Malformation: A Proof of Concept Phase I/II Trial Condition: Cerebral Cavernous Malformation Date: 2015-11-09 Interventions: Drug: Atorvastatin 20-80 mg OD |
Completed |
Study Name: Topical Timolol Gel for the Treatment of Infantile Hemangiomas Condition: Hemangioma Date: 2014-05-21 Interventions: Drug: timolol maleate 0.5% gel Apply timolol gel 1-2 drops twice a day to lesion |
Recruiting |
Study Name: Modifiers of Disease Severity in Cerebral Cavernous Malformations Condition: Cavernous Angioma, Familial Cerebral Cavernous Malformations Date: 2013-01-07 |
Completed |
Study Name: Permeability MRI in Cerebral Cavernous Malformations Type 1 in New Mexico: Effects of Statins Condition: Cavernous Angioma, Familial Cerebral Cavernous Malformations Date: 2013-01-07 Interventions: Drug: Simvastatin Other Name: Zocor |
Completed |
Study Name: A Prospective Controlled Study on Treatment of Giant Cavernous Hemangiomas of the Liver Condition: Laparoscopic Hepatectomy Radio-frequency Ablation Giant Date: 2011-11-09 Interventions: Procedure: RFA using RFA to tr |
Completed |
Study Name: Influence of MMP on Brain AVM Hemorrhage Condition: Arteriovenous Malformations Cavernous Angiomas Brain Aneur Date: 2008-10-30 Interventions: Drug: Doxycycline or Placebo Randomized to Doxycycline 100mg 2x/day or Placebo 2x/day for 1 or2-weeks pr |